MD : NYSE : Health Care
$60.08 up 0.43 | 0.72%
Today's Range: 59.4 - 60.17
Avg. Daily Volume: 1041800.0
06/28/17 - 11:57 AM ET

Financial Analysis


MEDNAX INC's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. MEDNAX INC has strong liquidity. Currently, the Quick Ratio is 1.65 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 12.27% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)835.6752.62
EBITDA ($mil)131.65143.82
EBIT ($mil)106.04124.23
Net Income ($mil)54.6967.9


Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)52.9864.28
Total Assets ($mil)5424.894636.29
Total Debt ($mil)1902.351442.7
Equity ($mil)2762.472460.41


Profitability Q1 FY17 Q1 FY16
Gross Profit Margin28.1731.06
EBITDA Margin15.7519.1
Operating Margin12.6916.51
Sales Turnover0.60.62
Return on Assets5.747.23
Return on Equity11.2813.63
Debt Q1 FY17 Q1 FY16
Current Ratio1.711.76
Debt/Capital0.410.37
Interest Expense17.7514.46
Interest Coverage5.978.59


Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)92.992.92
Div / share0.00.0
EPS0.590.73
Book value / share29.7326.48
Institutional Own % n/a n/a
Avg Daily Volume989291.0688893.0

Valuation


HOLD. This stock's P/E ratio indicates a discount compared to an average of 24.51 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 25.75. To use another comparison, its price-to-book ratio of 2.00 indicates a discount versus the S&P 500 average of 3.09 and a significant discount versus the industry average of 3.56. The price-to-sales ratio is below the S&P 500 average, but well above the industry average. Upon assessment of these and other key valuation criteria, MEDNAX INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MD 17.74 Peers 24.51   MD 12.27 Peers 14.23

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

MD is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

MD is trading at a discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
MD 14.90 Peers 17.26   MD 5.91 Peers 1.32

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

MD is trading at a valuation on par with its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MD trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MD 2.00 Peers 3.56   MD -6.41 Peers 16.90

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MD is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, MD is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MD 1.70 Peers 0.93   MD 12.88 Peers 10.31

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MD is trading at a significant premium to its industry.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

MD has a sales growth rate that exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades